drugset / Trial / NCT02789566

Pharmacokinetic Study of Primaquine in Healthy Obese Thai Adult Subjects

NCT02789566

Phase 1 Completed 10 enrolled University of Oxford
NaSingle-groupOpen-label

Summary

The primary objective of this study is to provide a description of the pharmacokinetic properties of primaquine and metabolites and characterize these in healthy obese Thai subjects. This is an open-label, single dose pharmacokinetic study in 10 healthy obese G6PD normal, subjects will be admitted as inpatient to receive 1 regimen for 1 visit only.

Timeline

Start
2011-08
Primary completion
2011-11
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Primaquine Small molecule 30 mg Oral

Indications